The benefits of engaging a CMO or CDMO for antibody development and production extend beyond fulfilling the needs of small companies; access to new technologies and operational flexibility are attractive attributes to larger players as well
Roots Analysis is pleased to announce the publication of its recent study, titled, “
According to experts in this field, the industry is investigating antibodies against novel targets which are expected to drive the market in the coming years. In fact, many service provider and platform provider companies are offering support to the medical research community in order to develop an appropriate intervention to treat the illness caused by the SARS-CoV-2 virus.
To order this 500+ page report, which features 120+ figures and 140+ tables, ... Read more
Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing
Roots Analysis is pleased to announce the publication of its recent study, titled, “ ... Read more
High target specificity and favorable safety profiles offered by antibody based pharmacological interventions has created a high demand for such molecules; the domain has witnessed an increased inflow of investments and collaboration opportunities.
The COVID-19 pandemic has severely impaired the overall pharmaceutical supply chain, mostly owing to the absence of workers at manufacturing sites and restrictions imposed on distribution networks. In this context, continuous manufacturing offers a viable solution given the fact that continuous processes are largely automated. In fact, the FDA (and other regulatory bodies) have also expressed interest in advocating a shift to the use of advanced manufacturing technologies,
To order this 450+ page report, please visit this link
Key Inclusions
An overview of the overall landscape of antibody discovery service providers along with the information on a number of parameters, such as year of establishment, company size, location of
Antibody therapeutics have made it possible to address the hard to target hotspots, rendering the domain of antibody discovery an emerging sector in the pharmaceutical industry; in fact,the antibodies have proven to be promising weapons in the battle against COVID-19 pandemic.
Roots Analysis is pleased to announce the publication of its recent study, titled, ... Read more
To order this 310+ page report, which features 110+ figures and 200+ tables, please visit this link
Key Inclusions
A detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing, along with information on a number of relevant parameters,
Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions
Roots Analysis is pleased to announce the publication of its recent study, titled, “ ... Read more
Over time, pharmaceutical players have demonstrated significant interest in this domain and have launched clinical research initiatives to investigate the relevance and applications of these novel biomarkers. Several companies have already developed / are developing analytical tests for novel cancer biomarkers (TMB, MSI / MMR and TILs), intended to assist physicians in making personalized treatment decisions.
To order this 370+ page report, which features 190+ ... Read more
It is estimated that around 80% of innovator companies rely on external companion diagnostic developers, mostly owing to the lack of the required in-house expertise. On the other hand, there are numerous contract service providers, offering vast portfolios of services for diagnostic test / assay development. Such companies are known to possess extensive technical knowledge, and experience in working with cutting-edge analytical tools and technologies, such as in situ
Roots Analysis has done a detailed report on Companion Diagnostics Development Services Market covering key aspects of the industry and identifying future growth opportunities
To order this 320+ page report, which features 120+ figures and 115+ tables, please visit this link
To order this detailed 320+ page report, please visit this link
Key Inclusions
A detailed assessment of the current market landscape of companies offering companion diagnostics services, including information on the type of services offered, type of analytical technique used and
In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertise
Roots Analysis is pleased to announce the publication of its recent study, titled, “ ... Read more
To order this detailed 370+ page report, please visit this link
Key Inclusions
A detailed analysis of ongoing, biomarker-based clinical trials initiated by big pharmaceutical companies, featuring details on immuno-oncology biomarkers and disease
The cell and advanced therapies supply chain is complex, with several legacy challenges, such as those related to patient scheduling, resource planning, inventory management, and deliverable tracking. A number of innovative, software-enabled systems are available / under development to mitigate the aforementioned concerns and simplify the management of biopharmaceutical supply chains.
To order this 510+ page report, which features 185+ figures and 400+ ... Read more
The growing biopharma industry in China has resulted in the creation of lucrative business opportunities for contract service providers; region-specific advantages have also attracted several foreign sponsors entities over the last few years
Roots Analysis is pleased to announce the publication of its recent study, titled, “ ... Read more
Autoinjectors have become an important part of modern healthcare, having demonstrated the potential to address a number of parenteral drug delivery related adverse events, and improve medication adherence among patients
In addition to enabling patients to self-medicate, these devices are designed to ensure safety during the dosing process and promote compliance to prescribed therapeutic regimens. Moreover, the adoption of autoinjectors, and other self-injection products, has enabled significant cost savings for end users by eliminating the need to visit hospitals / out-patient clinics for dosing.
To order this 600+ page report, which features 360+ figures and 350+ ... Read more
To order this detailed 600+ page report, please visit this link
Key Inclusions
An overview of the current market landscape of companies engaged in developing and / or manufacturing autoinjectors, providing information on the usability (disposable and reusable), type of primary drug container (cartridge, syringe
STING, having generated significant interest within the medical research community, is currently considered one of the fastest growing areas of cancer immunotherapy and is being pursued by several large pharmaceutical companies
Roots Analysis is pleased to announce the publication of its recent study, titled, “ ... Read more
In recent years, the concept of STING pathway targeting therapeutics has generated a lot of enthusiasm within the medical science community. The growing popularity of this therapeutic technique has not only garnered the interest of several medical researchers (reflected in the increasing volume of scientific literature (1,000+ articles published since 2015) on this subject), but also industry stakeholders focused on drug development (evident in the growing number of clinical ... Read more
The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity
